N4 Pharma (LON:N4P) Shares Down 7.1% – Here’s What Happened

N4 Pharma Plc (LON:N4P)’s stock price dropped 7.1% during trading on Thursday . The stock traded as low as GBX 0.65 ($0.01) and last traded at GBX 0.70 ($0.01). Approximately 13,901,041 shares changed hands during mid-day trading, an increase of 197% from the average daily volume of 4,678,713 shares. The stock had previously closed at GBX 0.75 ($0.01).

N4 Pharma Stock Up 11.1 %

The firm has a market cap of £2.96 million, a PE ratio of -55.00 and a beta of -0.37. The company has a quick ratio of 7.28, a current ratio of 22.73 and a debt-to-equity ratio of 1.62. The business has a 50-day moving average price of GBX 0.62 and a two-hundred day moving average price of GBX 0.58.

N4 Pharma Company Profile

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.